InnoPharmax Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	68.99	32.3	46.07	29.13	48.06
Revenue Growth (YoY)	113.60%	-29.90%	58.15%	-39.38%	-64.89%
Cost of Revenue	59.16	11.53	28.62	29.51	40.65
Gross Profit	9.83	20.76	17.46	-0.38	7.41
Selling, General & Admin	26.36	21.43	22.97	21.51	22.43
Research & Development	155.24	89.22	59.33	71.94	60.2
Operating Expenses	181.59	116.74	82.3	92.95	81.79
Operating Income	-171.76	-95.98	-64.84	-93.33	-74.37
Interest Expense	-0.38	-0.31	-0.37	-0.26	-0.4
Interest & Investment Income	2.84	1.92	1.64	0.98	1.01
Earnings From Equity Investments	-10.24	-8.12	-9.3	-5.82	-15.32
Currency Exchange Gain (Loss)	-	0.4	-0.07	-0.13	-0.79
Other Non Operating Income (Expenses)	-1.35	5.12	3.5	-4.6	0.06
EBT Excluding Unusual Items	-180.89	-96.97	-69.43	-103.15	-89.81
Gain (Loss) on Sale of Assets	-	-	-	-0.03	-
Asset Writedown	-	-	-1.4	-	-3.16
Pretax Income	-180.89	-96.97	-70.83	-103.18	-92.97
Income Tax Expense	3.51	2.32	-	-	-
Net Income	-184.4	-99.29	-70.83	-103.18	-92.97
Net Income to Common	-184.4	-99.29	-70.83	-103.18	-92.97
Shares Outstanding (Basic)	108	97	92	87	86
Shares Outstanding (Diluted)	108	97	92	87	86
Shares Change (YoY)	10.66%	5.83%	6.20%	0.31%	12.92%
EPS (Basic)	-1.71	-1.02	-0.77	-1.19	-1.08
EPS (Diluted)	-1.71	-1.02	-0.77	-1.19	-1.08
Free Cash Flow	-134.47	-76.75	-48.97	-100.08	-51.48
Free Cash Flow Per Share	-1.25	-0.79	-0.53	-1.15	-0.60
Gross Margin	14.25%	64.29%	37.89%	-1.29%	15.43%
Operating Margin	-248.98%	-297.18%	-140.73%	-320.35%	-154.76%
Profit Margin	-267.29%	-307.43%	-153.74%	-354.17%	-193.44%
Free Cash Flow Margin	-194.92%	-237.64%	-106.29%	-343.51%	-107.11%
EBITDA	-165.44	-93.92	-62.12	-89.41	-69.33
EBITDA Margin	-239.81%	-290.81%	-134.83%	-	-144.25%
D&A For EBITDA	6.33	2.06	2.72	3.92	5.05
EBIT	-171.76	-95.98	-64.84	-93.33	-74.37
EBIT Margin	-248.98%	-297.18%	-140.73%	-	-154.76%
Advertising Expenses	-	0.33	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.